Journal article
Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer
The American journal of pathology, v 185(9), pp 2505-2522
01 Sep 2015
PMID: 26362718
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Active Stat5a/b predicts early recurrence and disease-specific death in prostate cancer (PC), which both typically are caused by development of metastatic disease. Herein, we demonstrate that Stat5a/b induces epithelial-to-mesenchymal transition (EMT) of PC cells, as shown by Stat5a/b regulation of EMT marker expression (Twist1, E-cadherin, N-cadherin, vimentin, and fibronectin) in PC cell lines, xenograft tumors in vivo, and patient-derived PCs ex vivo using organ explant cultures. Jak2-Stat5a/b signaling induced functional end points of EMT as welt indicated by disruption of epithelial cell monolayers and increased migration and adhesion of PC cells to fibronectin. Knockdown of Twist1 suppressed Jak2-Stat5a/b induced EMT properties of PC cells, which were rescued by re-introduction of Twist1, indicating that Twist1 mediates Stat5a/b-induced EMT in PC cells. White promoting EMT, Jak2-Stat5a/b signaling induced stem-Like properties in PC cells, such as sphere formation and expression of cancer stem cell markers, including BMI1. Mechanistically, both Twist1 and BMI1 were critical for Stat5a/b induction of stem-like features, because genetic knockdown of Twist1 suppressed Stat5a/b-induced BMI1 expression and sphere formation in stem cell culture conditions, which were rescued by re-introduction of BMI1. By using human prolactin knock-in mice, we demonstrate that prolactin-Stat5a/b signaling promoted metastases formation of PC cells in vivo. In conclusion, our data support the concept that Jak2-Stat5a/b signaling promotes metastatic progression of PC by inducing EMT and stem cell properties in PC cells.
Metrics
Details
- Title
- Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer
- Creators
- Pooja G. Talati - Thomas Jefferson UniversityLei Gu - Thomas Jefferson UniversityElyse M. Ellsworth - Thomas Jefferson UniversityMelanie A. Girondo - Thomas Jefferson UniversityMarco Trerotola - Thomas Jefferson UniversityDavid T. Hoang - Thomas Jefferson UniversityBenjamin Leiby - Thomas Jefferson UniversityAyush Dagvadorj - Thomas Jefferson UniversityPeter A. McCue - Thomas Jefferson UniversityCostas D. Lallas - Thomas Jefferson UniversityEdouard J. Trabulsi - Thomas Jefferson UniversityLeonard Gomella - Thomas Jefferson UniversityAndrew E. Aplin - Thomas Jefferson UniversityLucia Languino - Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania; Prostate Cancer Discovery and Development Program, Wistar Institute, Philadelphia, Pennsylvania.Alessandro Fatatis - Drexel UniversityHallgeir Rui - Thomas Jefferson UniversityMarja T. Nevalainen - Thomas Jefferson University
- Publication Details
- The American journal of pathology, v 185(9), pp 2505-2522
- Publisher
- Elsevier
- Number of pages
- 18
- Grant note
- R21CA178755 / NATIONAL CANCER INSTITUTE; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) 2RO1CA11358-06; 1R21CA178755-01; CA185918; CA188575; CA160495 / NIH/NCI; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI) CA56036-08 / NIH Cancer Center; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Pharmacology and Physiology
- Web of Science ID
- WOS:000361421800016
- Scopus ID
- 2-s2.0-84941053082
- Other Identifier
- 991019168187804721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Pathology